Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00722306 · ClinicalTrials.gov registry record · Phase 1
A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00722306 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 6 participants.
The verdict
NCT00722306, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
To determine the mass balance of PD 0200390
Interventions
- DRUG PD 0200390
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00722306
The ClinicalTrials.gov registry entry for NCT00722306 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PD 0200390 is the first listed.
NCT00722306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00722306 about?
NCT00722306 is a clinical study titled "A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers". To determine the mass balance of PD 0200390
What is the current status of trial NCT00722306?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2008-05. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00722306?
The interventions under investigation include: PD 0200390 (DRUG).
Who is sponsoring clinical trial NCT00722306?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.